Navigation Links
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
Date:11/12/2008

ations management, healthcare utilization and organizational planning at Bayer Corporation and Wyeth Pharmaceuticals (formerly Ayerst Laboratories). Ms. Graham holds a B.A. in biology from the University of Delaware and an M.B.A. from the University of Connecticut.

About TorreyPines Therapeutics, Inc.

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity, xerostomia and cognitive disorders. The company is currently developing three product candidates: two ionotropic glutamate receptor antagonists and one muscarinic receptor agonist. Further information is available at http://www.torreypinestherapeutics.com.

This press release contains forward-looking statements or predictions. Such statements are subject to numerous known and unknown risks, uncertainties and other factors, which may cause TorreyPines' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These and other risks which may cause results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K for the year ended December 31, 2007 and TorreyPines other SEC reports. The forward-looking statements are based on current information that is likely to change and speak only as of the date hereof.

Company contact: Investor contact:

Paul Schneider Rhonda Chiger

TorreyPines Therapeutics, Inc. Rx Communications Group

858-623-5665
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
2. TorreyPines Therapeutics Sells Alzheimers Disease Genetics Program to Eisai
3. TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
4. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
5. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
6. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
10. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
11. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 As one of the 10 largest ... Meeting & Clinical Lab Expo is the place where ... introduced to the healthcare world. This year, many of ... will include the latest diagnostic technology in the field ... and biosensors have enabled the development of "labs-on-a-chip" that ...
(Date:8/1/2014)... , Aug. 1, 2014 Research and ... "Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market ... http://photos.prnewswire.com/prnh/20130307/600769 Single Nucleotide Polymorphism ... variations of SNPs in the genome of various species. ... SNP genotyping and analysis technology can analyze thousands of ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Testing ... led to a better understanding embryonic development. ... reorganize into structurally and functionally distinct tissues is ... defects. Prof. Todd McDevitt, Melissa Kinney, and ... signals interact with biochemical cues to control many ...
(Date:7/31/2014)... There,s a good reason people over 60 are not ... ages and weakens with time, making the elderly prone ... San Francisco research team now has discovered a reason ... for the inability of blood-forming cells to maintain blood ... identified molecular defects that could be restored for rejuvenation ...
Breaking Biology Technology:Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2Key to aging immune system is discovered 2
... , , , SADDLE RIVER, ... a leading provider of sales and marketing support to U.S. pharmaceutical companies, today ... highlights include: , , , Four new ... Signed agreement with The Medical Affairs Company (TMAC(R)) to enhance our ...
... SAN DIEGO, Aug. 5 Orexigen(R) Therapeutics, Inc. (Nasdaq: ... announced that the Company will be speaking at the 29th Annual Canaccord ... , , Date: Thursday, ... Location: InterContinental Boston, London Room, Speaker: Michael ...
... DIEGO, Aug. 5 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... on Wednesday, August 12, 2009 at 1:30 p.m. Pacific (4:30 p.m. ... an update on its business. , , Individuals ... dialing (866) 305-6438 for domestic callers, or (706) 679-7161 for international ...
Cached Biology Technology:PDI Reports 2009 Second Quarter Financial Results 2PDI Reports 2009 Second Quarter Financial Results 3PDI Reports 2009 Second Quarter Financial Results 4PDI Reports 2009 Second Quarter Financial Results 5PDI Reports 2009 Second Quarter Financial Results 6PDI Reports 2009 Second Quarter Financial Results 7PDI Reports 2009 Second Quarter Financial Results 8PDI Reports 2009 Second Quarter Financial Results 9
(Date:8/1/2014)... Scripps Research Institute (TSRI) have identified a signaling pathway ... fat cells. , The study, which is reported ... Proceedings of the National Academy of Sciences , sheds ... which is of great interest to medical researchers because ... against diabetes. , "This finding offers new possibilities for ...
(Date:8/1/2014)... 1, 2014  LiveScan Service Provider Binary Biometrics is pleased to ... result, Binary Biometrics will improve its mobile service capabilities and add more daily ... and service several new cities such as, but not limited to, ... DeLand , Deltona , Edgewater , ... New Smyrna Beach , Oak Hill , ...
(Date:7/31/2014)... United States, natural-gas production from shale rock has ... Yet scientists still do not fully understand the ... a report in the journal Frontiers in ... extraction continues to vastly outpace scientific examination, a ... and institutions, including Princeton University, concluded that determining ...
Breaking Biology News(10 mins):Scripps Research Institute scientists find new calorie-burning switch in brown fat 2Scripps Research Institute scientists find new calorie-burning switch in brown fat 3Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 2Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 3'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3
... had been suggested that the origin of pumpkins and cucumbers ... confirmed on the basis of genetic analyses performed by German ... access journal PhytoKeys . Vegetables are ... India but around the globe. Compared to grains and pulses, ...
... at Uppsala University, Sweden, has been granted funding for digitising ... make the valuable plants available to the whole world, online. ... Carl Thunberg travelled with the Dutch East India Company to ... he collected almost 28,000 plants on his journey, of which ...
... about ground-level ozone in American cities. While dangerous ozone ... emissions from vehicles and industry, a new study from ... predict the impact of remediation efforts has been too ... even beyond what was anticipated by cutting emissions of ...
Cached Biology News:New genetic study confirms Indian origins of pumpkins and cucumbers 2Carl Thunberg's Japanese plants to be digitized 2Ground-level ozone falling faster than model predicted 2
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
... and rocking for maximal fluid movement. This unit ... steel or acrylic platform, it is perfect for ... platform angle is easily adjusted from 0 to ... rotation speed of platform is adjusted from 0 ...
...
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
Biology Products: